| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 150 | $1,460 | $225.1K |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 180 | $490 | $90K |
| 78816 | The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The… | 40 | $1,460 | $64.3K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 170 | $280 | $46.9K |
| 77067 | The provider takes two X–ray views of each breast for routine screening and may use specially designed computer software to help identify any potential abnormalities within the images; the software… | 390 | $60 | $21.3K |
| 77063 | The provider captures three dimensional images of the breast using X–rays at various angles for routine checkup. He checks for the presence of any abnormality within the breasts. Tomosynthesis… | 340 | $30 | $11.6K |
| 72197 | In this diagnostic procedure, the provider performs magnetic resonance imaging (MRI) of the pelvis first without using contrast and again after injecting contrast material. | 20 | $300 | $7.2K |
| 78452 | In this procedure, the provider performs multiple SPECT studies of the heart to determine the areas of deficient blood flow. The goal of the procedure is to determine areas that have deficient blood… | 10 | $390 | $5K |
| 77049 | The provider obtains images of both breasts by applying an external magnetic field and radiofrequency waves to create three–dimensional images, with and without contrast; he may also perform… | 40 | $120 | $4.2K |
| 19083 | Under ultrasound guidance, the provider takes breast tissue percutaneously from a single lesion for biopsy. He may place a localization device at the same time. | 30 | $120 | $3.8K |